Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)
Pacific Biosciences Of California's quarterly Other Non-Current Assets came in at $1.6 million in Q1 2026, down 28.44% year-on-year from $2.2 million in Q1 2025, and up 3.79% quarter-over-quarter from $1.5 million in Q4 2025.
Pacific Biosciences Of California has reported Other Non-Current Assets for 17 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 28.44% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 28.44% YoY), and the FY2025 full-year result was $1.5 million, down 83.54% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.6 million, up from $1.5 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $9.3 million in Q4 2024, with the low at $1.5 million in Q2 2025.
- Average Other Non-Current Assets over 5 years is $3.0 million, with a median of $2.7 million recorded in 2023.
- Year-over-year, Other Non-Current Assets surged 241.84% in 2024 and tumbled 83.54% in 2025.
- Tracing PACB's Other Non-Current Assets over 5 years: stood at $3.2 million in 2022, then dropped by 15.52% to $2.7 million in 2023, then surged by 241.84% to $9.3 million in 2024, then plunged by 83.54% to $1.5 million in 2025, then rose by 3.79% to $1.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 9.31 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Jun 30, 2021 | 3.30 Mn |
| Mar 31, 2021 | 4.34 Mn |
| Dec 31, 2020 | 4.34 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 3.50 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Sep 30, 2019 | 4.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 4.50 Mn |
| Dec 31, 2018 | 4.80 Mn |
| Sep 30, 2018 | 4.50 Mn |
| Jun 30, 2018 | 4.50 Mn |
| Mar 31, 2018 | 4.50 Mn |
| Dec 31, 2017 | 4.50 Mn |
| Sep 30, 2017 | 188,000.00 |
| Jun 30, 2017 | 4.50 Mn |
| Mar 31, 2017 | 219,000.00 |
| Dec 31, 2016 | 4.50 Mn |
| Sep 30, 2016 | 4.50 Mn |
| Jun 30, 2016 | 5.00 Mn |
| Mar 31, 2016 | 4.50 Mn |
| Dec 31, 2015 | 358,000.00 |
| Sep 30, 2015 | 5.72 Mn |
| Jun 30, 2015 | 153,000.00 |
| Mar 31, 2015 | 156,000.00 |
| Dec 31, 2014 | 29,000.00 |
| Sep 30, 2014 | 471,000.00 |
| Jun 30, 2014 | 482,000.00 |
| Mar 31, 2014 | 486,000.00 |
| Dec 31, 2013 | 490,000.00 |
| Sep 30, 2013 | 493,000.00 |
| Jun 30, 2013 | 508,000.00 |
| Dec 31, 2012 | 354,000.00 |
| Mar 31, 2012 | 340,000.00 |
| Dec 31, 2011 | 317,000.00 |
| Sep 30, 2011 | 319,000.00 |
| Jun 30, 2011 | 312,000.00 |
| Dec 31, 2010 | 322,000.00 |